TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25331879

Group type: EXPERIMENTAL
Intervention: Financial incentives for accuracy in evaluating the opposing party
Number of subjects: 2962

Group type: COMPARATOR
Intervention: Ingroup love attribution
Number of subjects: 2962

Group type: COMPARATOR
Intervention: Outgroup hate attribution
Number of subjects: 2962

Group type: COMPARATOR
Intervention: Bias in attribution
Number of subjects: 2962
Study: 22982183

Group type: EXPERIMENTAL
Intervention: Biliary sphincterotomy (BES)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Combined biliary and pancreatic sphincterotomy (DES)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Sham surgery
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Patients with SOD
Number of subjects: 89
Study: 19216655

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (10 sessions)
Number of subjects: 127
Study: 17990836

Group type: EXPERIMENTAL
Intervention: Long-acting inhaled anticholinergics
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroids
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Long-acting inhaled anticholinergics, inhaled corticosteroids, possibly long-acting beta2 agonist or mucolytics
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Short-acting beta2 agonists or combination anticholinergics with a short-acting beta2 agonist
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Continuous oxygen
Number of subjects: 0
Study: 16118771

Group type: EXPERIMENTAL
Intervention: Bevacizumab (5 mg/kg)
Number of subjects: 230

Group type: COMPARATOR
Intervention: Control (chemotherapy alone)
Number of subjects: 230
Study: 11990232

Group type: EXPERIMENTAL
Intervention: Educational intervention based on a readiness model; duration: three months.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned in the abstract).
Number of subjects: 0
Study: 9582203

Group type: EXPERIMENTAL
Intervention: Vibration of extensor carpi radialis (ECR) tendon
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vibration of extensor carpi ulnaris (ECU) tendon
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vibration of extensor digitorum (ED) tendon
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combinations of ECR, ECU, and ED tendon vibrations
Number of subjects: 0
Study: 7658874

Group type: EXPERIMENTAL
Intervention: Bosentan (100 mg followed after 60 min by 200 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 2541741

Group type: EXPERIMENTAL
Intervention: Enalapril 10 mg
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Enalapril 20 mg
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Enalapril 40 mg
Number of subjects: 116

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116
Study: 1089090

Group type: EXPERIMENTAL
Intervention: Marijuana smoking (12 mg delta9‐tetrahydrocannabinol)
Number of subjects: 0
Study: 31859127

Group type: EXPERIMENTAL
Intervention: High Saturated Fat (HSF) meal
Number of subjects: 15

Group type: COMPARATOR
Intervention: High-carbohydrate meal
Number of subjects: 15
Study: 31084482

Group type: EXPERIMENTAL
Intervention: Subtraction CT iodine maps
Number of subjects: 274

Group type: COMPARATOR
Intervention: CT angiography
Number of subjects: 274

Group type: COMPARATOR
Intervention: Dual-energy CT
Number of subjects: 274

Group type: COMPARATOR
Intervention: Subtraction CT
Number of subjects: 274

Group type: EXPERIMENTAL
Intervention: All techniques
Number of subjects: 274
Study: 28351427

Group type: EXPERIMENTAL
Intervention: Whole-genome sequencing (WGS)
Number of subjects: 36

Group type: COMPARATOR
Intervention: MIRU-VNTR typing
Number of subjects: 36
Study: 24285583

Group type: EXPERIMENTAL
Intervention: Connections (correspondence-based interactive recovery-oriented intervention)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Information (psychoeducational booklet)
Number of subjects: 81
Study: 22689129

Group type: EXPERIMENTAL
Intervention: 1 g of POMx
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: 3 g of POMx
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 104
Study: 21679641

Group type: EXPERIMENTAL
Intervention: Distal venous arterialization (DVA)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Conservative treatment (CT)
Number of subjects: 36
Study: 18804874

Group type: EXPERIMENTAL
Intervention: Once weekly water exercise (60 minutes, 1 session per week for 2 years)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Twice weekly water exercise (60 minutes, 2 sessions per week for 2 years)
Number of subjects: 0
Study: 16628277

Group type: EXPERIMENTAL
Intervention: GH (0.050 U/kg/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 15358335

Group type: EXPERIMENTAL
Intervention: Drain group
Number of subjects: 170

Group type: COMPARATOR
Intervention: No-drain group
Number of subjects: 170
Study: 12712351

Group type: EXPERIMENTAL
Intervention: Running training (runners)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Non-running (non-runners)
Number of subjects: 10
Study: 10370793

Group type: EXPERIMENTAL
Intervention: Paclitaxel 200 mg/m2 by three-hour infusion on day 1 and gemcitabine 1100 mg/m2 over 30 min on days 1 and 8, repeated every three weeks for six cycles.
Number of subjects: 44
Study: 7613276

Group type: EXPERIMENTAL
Intervention: Selective serotonin reuptake inhibitors
Number of subjects: 6029

Group type: COMPARATOR
Intervention: Tricyclic antidepressants
Number of subjects: 6029
Study: 2353093

Group type: EXPERIMENTAL
Intervention: Combined tracing-thresholding technique
Number of subjects: 10
Study: 93982

Group type: EXPERIMENTAL
Intervention: Streptozotocin combined with 5-fluorouracil (5-FU)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Streptozotocin combined with cyclophosphamide
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Crossover therapy with 5-FU alone
Number of subjects: 118

Group type: COMPARATOR
Intervention: Cyclophosphamide alone
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Overall response rates for carcinoids of pulmonary or unknown origin
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Median survival times by tumor origin
Number of subjects: 118
Study: 28273028

Group type: EXPERIMENTAL
Intervention: Imatinib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Interferon alfa plus cytarabine
Number of subjects: 0
Study: 25542520

Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 1185

Group type: EXPERIMENTAL
Intervention: Ranibizumab
Number of subjects: 1185

Group type: COMPARATOR
Intervention: Monthly treatment
Number of subjects: 1185

Group type: EXPERIMENTAL
Intervention: Subfoveal CNV lesions
Number of subjects: 1185

Group type: EXPERIMENTAL
Intervention: Distance from fovea
Number of subjects: 1185

Group type: EXPERIMENTAL
Intervention: Predominantly classic lesions
Number of subjects: 1185

Group type: EXPERIMENTAL
Intervention: Minimally classic lesions
Number of subjects: 1185

Group type: EXPERIMENTAL
Intervention: Occult only lesions
Number of subjects: 1185

Group type: EXPERIMENTAL
Intervention: Fellow eye with GA
Number of subjects: 1185

Group type: EXPERIMENTAL
Intervention: Epiretinal membrane
Number of subjects: 1185
Study: 23669188

Group type: EXPERIMENTAL
Intervention: Warm footbath (40°C water temperature, 20‐min duration)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Non-bathing
Number of subjects: 25
Study: 21842017

Group type: EXPERIMENTAL
Intervention: Cervitec varnish
Number of subjects: 250

Group type: COMPARATOR
Intervention: Gluma varnish
Number of subjects: 250
Study: 19390239

Group type: EXPERIMENTAL
Intervention: Pranlukast hydrate plus oral mequitazine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fexofenadine hydrochloride plus oral mequitazine
Number of subjects: 0
Study: 17078057

Group type: EXPERIMENTAL
Intervention: Telephone monitoring (TM) + Educational materials (EM)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Educational materials (EM)
Number of subjects: 192
Study: 14742342

Group type: EXPERIMENTAL
Intervention: Bolus dose of rocuronium
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Continuous infusion of rocuronium
Number of subjects: 20
Study: 11707740

Group type: EXPERIMENTAL
Intervention: Renal transplantation
Number of subjects: 27
Study: 9164208

Group type: EXPERIMENTAL
Intervention: Paclitaxel 150 mg/m2
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Paclitaxel 175 mg/m2
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Paclitaxel 200 mg/m2
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Paclitaxel 225 mg/m2
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Paclitaxel 250 mg/m2
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Paclitaxel 275 mg/m2
Number of subjects: 23
Study: 11548230

Group type: EXPERIMENTAL
Intervention: Gonarthrosis patients
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Gonarthrosis patients (unilateral GA)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Healthy controls (women)
Number of subjects: 27
Study: 29897822

Group type: EXPERIMENTAL
Intervention: 300 kcal/exercise session, 5 days/wk for 12 wk
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 600 kcal/exercise session, 5 days/wk for 12 wk
Number of subjects: 36

Group type: COMPARATOR
Intervention: 1,500 kcal/wk ExEE
Number of subjects: 36

Group type: COMPARATOR
Intervention: 3,000 kcal/wk ExEE
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Resting metabolic rate
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Energy intake
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Food reinforcement
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Glucagon-like peptide-1
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Acylated ghrelin
Number of subjects: 36
Study: 27108672

Group type: EXPERIMENTAL
Intervention: lurasidone 40 mg
Number of subjects: 54

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 54
Study: 25470096

Group type: EXPERIMENTAL
Intervention: RUL brief‐pulse ECT (mean dose = 233.3 mC)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Algorithm‐based pharmacologic treatment (APT)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: RUL brief‐pulse ECT
Number of subjects: 73
Study: 22826463

Group type: EXPERIMENTAL
Intervention: [(14)C]β‐sitosterol administered orally
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: [(14)C]β‐sitosterol administered intravenously
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dietary load of β‐sitosterol
Number of subjects: 0
Study: 20655180

Group type: EXPERIMENTAL
Intervention: Metoclopramide 10mg intravenously
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 5-HTP 200 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Metoclopramide alone
Number of subjects: 12

Group type: COMPARATOR
Intervention: 5-HTP test alone
Number of subjects: 12

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 12
Study: 18240288

Group type: EXPERIMENTAL
Intervention: Mobile phone-like RF exposure (1 W/kg for 30 min via a 900 MHz GSM mobile phone)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no RF exposure)
Number of subjects: 30
Study: 16754838

Group type: EXPERIMENTAL
Intervention: Schema-focused therapy (SFT)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Transference-focused psychotherapy (TFP)
Number of subjects: 88
Study: 12534636

Group type: EXPERIMENTAL
Intervention: Ropivacaine 50 mg, 100 mg, and 200 mg base as 20-ml gel enemas
Number of subjects: 32
Study: 10817324

Group type: EXPERIMENTAL
Intervention: Indicator double gloves
Number of subjects: 566

Group type: COMPARATOR
Intervention: Single gloves
Number of subjects: 566
Study: 8844274

Group type: EXPERIMENTAL
Intervention: MART1
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: MART3
Number of subjects: 16

Group type: COMPARATOR
Intervention: MART5
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: MART (all protocols)
Number of subjects: 16
Study: 1621138

Group type: EXPERIMENTAL
Intervention: Drug treatment (classical tranquilizers)
Number of subjects: 1168

Group type: COMPARATOR
Intervention: Psychotherapy
Number of subjects: 1168

Group type: EXPERIMENTAL
Intervention: General practitioners
Number of subjects: 1168

Group type: EXPERIMENTAL
Intervention: Medical health care providers
Number of subjects: 1168
Study: 6363962

Group type: EXPERIMENTAL
Intervention: iohexol
Number of subjects: 38

Group type: COMPARATOR
Intervention: metrizamide
Number of subjects: 38
Study: 30700475

Group type: COMPARATOR
Intervention: Standard sequential chemoradiotherapy schedule of 55 Gy in 20 fractions over 4 weeks
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Experimental radiotherapy schedules (4 separate dose escalation accelerated radiotherapy schedules)
Number of subjects: 360
Study: 29033279

Group type: EXPERIMENTAL
Intervention: 8-session guided self-help CBT intervention for distressing voices
Number of subjects: 28

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 28
Study: 27362935

Group type: EXPERIMENTAL
Intervention: Combination therapy of anti-CD138-IFNα14 and bortezomib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bortezomib
Number of subjects: 0

Group type: COMPARATOR
Intervention: anti-CD138-IFNα14
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 0
Study: 25274764

Group type: EXPERIMENTAL
Intervention: Closed blood conservation device
Number of subjects: 284

Group type: COMPARATOR
Intervention: Conventional 3-way stopcock
Number of subjects: 284
Study: 22264575

Group type: EXPERIMENTAL
Intervention: Control of 0 of 4 risk factors
Number of subjects: 4182

Group type: EXPERIMENTAL
Intervention: Control of 1 of 4 risk factors
Number of subjects: 4182

Group type: EXPERIMENTAL
Intervention: Control of 2 of 4 risk factors
Number of subjects: 4182

Group type: EXPERIMENTAL
Intervention: Control of 3 of 4 risk factors
Number of subjects: 4182

Group type: EXPERIMENTAL
Intervention: Control of 4 of 4 risk factors
Number of subjects: 4182
Study: 19418327

Group type: EXPERIMENTAL
Intervention: Kurakkan flour roti
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rice flour roti
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Atta flour roti
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Boiled breadfruit
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Boiled legumes (mungbean, cowpea, chickpea)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Kurakkan flour pittu
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Wheat flour roti
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hoppers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rice flour pittu
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Wheat flour pittu
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Olu-milk rice
Number of subjects: 0
Study: 17372173

Group type: EXPERIMENTAL
Intervention: hs-CRP levels 1 to 3 mg/L
Number of subjects: 3771

Group type: EXPERIMENTAL
Intervention: hs-CRP levels >3 mg/L
Number of subjects: 3771

Group type: EXPERIMENTAL
Intervention: Elevated hs-CRP levels
Number of subjects: 3771
Study: 16178190

Group type: EXPERIMENTAL
Intervention: Fixed-Twin-block (TB1)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Unfixed-Twin-block (TB2)
Number of subjects: 56
Study: 12480423

Group type: EXPERIMENTAL
Intervention: Sputum management group
Number of subjects: 74

Group type: COMPARATOR
Intervention: BTS management group
Number of subjects: 74
Study: 9657513

Group type: EXPERIMENTAL
Intervention: CGP 56697 (artemether and benflumetol)
Number of subjects: 260

Group type: COMPARATOR
Intervention: Chloroquine
Number of subjects: 260
Study: 8130019

Group type: EXPERIMENTAL
Intervention: Dipyridamole
Number of subjects: 30

Group type: COMPARATOR
Intervention: Dobutamine
Number of subjects: 30
Study: 2490928

Group type: EXPERIMENTAL
Intervention: High concentration mouthwash (0.16% sodium chloride in an activating system)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Low concentration mouthwash (0.04% sodium chloride, comparably activated)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo mouthwash (activating system alone)
Number of subjects: 18
Study: 776350

Group type: EXPERIMENTAL
Intervention: Methyldopa 750 mg/day combined with propranolol 240 mg/day
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Methyldopa 750 mg/day combined with practolol 600 mg/day
Number of subjects: 24

Group type: COMPARATOR
Intervention: Methyldopa 750 mg/day
Number of subjects: 24

Group type: COMPARATOR
Intervention: Propranolol 240 mg/day
Number of subjects: 24

Group type: COMPARATOR
Intervention: Practolol 600 mg/day
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 30905211

Group type: EXPERIMENTAL
Intervention: Educational program for asthma care
Number of subjects: 78

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: ICS/LABA treatment
Number of subjects: 78
Study: 31331193

Group type: EXPERIMENTAL
Intervention: Anacetrapib 100 mg daily
Number of subjects: 19210

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19210

Group type: EXPERIMENTAL
Intervention: Anacetrapib
Number of subjects: 19210
Study: 27796852

Group type: EXPERIMENTAL
Intervention: Stress myocardial perfusion imaging (MPI)
Number of subjects: 303

Group type: COMPARATOR
Intervention: Coronary computed tomographic angiography (CCTA)
Number of subjects: 303
Study: 25875383

Group type: EXPERIMENTAL
Intervention: Sublingual nitroglycerin (NTG) doses of 10, 20, 30, and 40 μg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Flow-mediated dilatation (FMD)
Number of subjects: 24
Study: 24228630

Group type: EXPERIMENTAL
Intervention: Web-based self-help intervention combined with chat counseling
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Web-based self-help intervention alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 0
Study: 21865363

Group type: EXPERIMENTAL
Intervention: Ethinyl estradiol‐cyproterone acetate (EE‐CA)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Low-dose pioglitazone-flutamide-metformin (PioFluMet)
Number of subjects: 34
Study: 19262436

Group type: EXPERIMENTAL
Intervention: Intravitreal bevacizumab (1.25 mg/0.05 mL) before PRP
Number of subjects: 41

Group type: COMPARATOR
Intervention: Panretinal photocoagulation (PRP) alone
Number of subjects: 41
Study: 17407624

Group type: EXPERIMENTAL
Intervention: Fixed combination brimonidine-timolol (FCBT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Fixed combination dorzolamide-timolol (FCDT)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both FCBT and FCDT
Number of subjects: 30
Study: 15778167

Group type: EXPERIMENTAL
Intervention: Women take PRIDE program
Number of subjects: 457

Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 457
Study: 11498263

Group type: EXPERIMENTAL
Intervention: T cells producing interferon‐gamma (IFN‐gamma)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: T cells producing interleukin (IL)‐4
Number of subjects: 13
Study: 9711427

Group type: EXPERIMENTAL
Intervention: Gemfibrozil therapy for 12 weeks
Number of subjects: 27
Study: 8040675

Group type: COMPARATOR
Intervention: Tamoxifen 20 mg/d orally
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: MPA 1 g/d orally
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Tamoxifen after MPA
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: MPA after Tamoxifen
Number of subjects: 182
Study: 2689895

Group type: EXPERIMENTAL
Intervention: Single basal immunofluorometric (IFMA) TSH measurement
Number of subjects: 103

Group type: COMPARATOR
Intervention: TRH test with RIA‐TSH measurements
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Basal TSH measurement
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Measurement of TT4 and/or FT4I
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Substitution therapy with thyroxine
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: 2‐yr follow‐up of patients with subclinical thyroid dysfunction
Number of subjects: 103
Study: 791472

Group type: EXPERIMENTAL
Intervention: Combination of fluorouracil, methyl‐CCNU, and vincristine
Number of subjects: 91

Group type: COMPARATOR
Intervention: Fluorouracil alone
Number of subjects: 91
Study: 30098028

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 0
Study: 27208331

Group type: EXPERIMENTAL
Intervention: D/N‐AP
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: E/N‐AP
Number of subjects: 20

Group type: COMPARATOR
Intervention: SAP
Number of subjects: 20
Study: 24632426

Group type: EXPERIMENTAL
Intervention: Selective pulmonary perfusion (sPP) with venous blood at 2°C, 4 l
Number of subjects: 59

Group type: COMPARATOR
Intervention: Standard cardiopulmonary bypass (CPB)
Number of subjects: 59
Study: 22856459

Group type: EXPERIMENTAL
Intervention: Lifestyle modification program (LMP) involving individual and group sessions
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Lifestyle modification program (LMP)
Number of subjects: 301
Study: 19857367

Group type: EXPERIMENTAL
Intervention: 48 g Resistant Starch (RS)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 17921377

Group type: EXPERIMENTAL
Intervention: Glucose and 2.4 g amino acid kg(‐1) d(‐1)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Glucose only (control group)
Number of subjects: 15
Study: 16076947

Group type: EXPERIMENTAL
Intervention: Pegvisomant (10 mg/d)
Number of subjects: 53
Study: 11966672

Group type: EXPERIMENTAL
Intervention: 300 mg moclobemide coadministration with 40 mg omeprazole
Number of subjects: 16

Group type: COMPARATOR
Intervention: 40 mg omeprazole alone
Number of subjects: 16
Study: 10566525

Group type: EXPERIMENTAL
Intervention: Outpatient intra‐anal electromyographic biofeedback training
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Electromyographic biofeedback training plus intrarectal balloon training
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Electromyographic biofeedback training plus home training
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Electromyographic biofeedback training, balloon training, and home training
Number of subjects: 36